ESR1 and breast carcinoma: Currently, a significant proportion of breast cancer patients received adjuvant systemic chemotherapy since meta-analysis results have shown that adjuvant systemic chemotherapy is beneficial regardless of the age and estrogen receptor (ER) expression [2].